Influvac Injektionssuspension

Land: Schweiz

Sprache: Italienisch

Quelle: Swissmedic (Swiss Agency for Therapeutic Products)

Wirkstoff:

haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singapore/GP1908/2015), haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Singapore/INFIMH-16-0019/2016 (H3N2)-like: reassortant virus NIB-104), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A (Victoria lineage))

Verfügbar ab:

BGP Products GmbH

ATC-Code:

J07BB02

INN (Internationale Bezeichnung):

haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singa

Darreichungsform:

Injektionssuspension

Zusammensetzung:

haemagglutininum influenzae di tipo A (H1N1) (Virus-Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derivato da A/Singapore/GP1908/2015) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Singapore/INFIMH-16-0019/2016 (H3N2)-come: reassortant virus PENNINO-104) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Colorado/06/2017-come: reassortant virus (B/Veneto/15/2016 NYMC BX-69A (Victoria lignaggio)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0,1 µg, formaldehydum e cetrimidum e polysorbatum 80 e gentamicinum nihil, aqua ad iniectabilia q s. annuncio suspensionem pro 0,5 ml.

Therapiegruppe:

Impfstoffe

Therapiebereich:

aktive Immunisierung gegen Influenza, ab dem vollendeten 6. Lebensmonat

Berechtigungsdatum:

1988-06-24